A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Context Therapeutics Inc.
Context Therapeutics Inc.
AstraZeneca
Xencor, Inc.
BioNTech SE
Massive Bio, Inc.
BioNTech SE
Seagen Inc.
Astellas Pharma Inc
Taproot Health
DxTerity Diagnostics
Power Life Sciences Inc.
Endocyte
SpeciCare
Celgene
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
INSYS Therapeutics Inc
Alaunos Therapeutics
Mannkind Corporation